For most seniors, the safest first-line approach to better sleep isn’t a pill at all. It’s a structured behavioral program called cognitive behavioral therapy for insomnia (CBT-I), which outperforms common sleep medications in both short- and long-term outcomes for older adults. When a sleep aid is needed, low-dose melatonin (0.3 to 2 mg) and a newer class of prescription medications called orexin receptor antagonists have the most favorable safety profiles for people over 65.
The answer matters because aging changes how the body processes drugs. Slower metabolism, increased sensitivity to sedation, and higher fall risk make many popular sleep aids genuinely dangerous for older adults. Several options sold as “gentle” or available without a prescription actually carry serious risks that younger adults rarely face.
Why Common OTC Sleep Aids Are Risky After 65
The most widely used over-the-counter sleep aids, including the active ingredient in Benadryl and many “PM” branded pain relievers, contain diphenhydramine. This antihistamine is specifically listed on the American Geriatrics Society’s Beers Criteria, a widely referenced list of medications considered potentially inappropriate for older adults. The problem is its strong anticholinergic activity, which means it blocks a chemical messenger involved in memory, digestion, and muscle control.
In seniors, diphenhydramine’s clearance from the body slows significantly. The result is a higher risk of confusion, dry mouth, constipation, urinary retention, falls, and delirium. A prospective study found that higher cumulative use of strong anticholinergic drugs, including first-generation antihistamines like diphenhydramine, is associated with an increased risk of dementia. This isn’t a minor statistical signal. It’s enough that geriatric specialists broadly recommend avoiding these drugs in older adults entirely, even for occasional use.
Doxylamine, the antihistamine in NyQuil and Unisom SleepTabs, carries similar anticholinergic risks and the same warnings apply.
Behavioral Therapy Outperforms Medication
CBT-I is a short-term, structured program (typically 4 to 8 sessions) that retrains sleep habits and addresses the thought patterns that keep people awake. It doesn’t involve medication. A clinical trial published in JAMA compared CBT-I to zopiclone (a prescription sedative similar to Ambien) in older adults and found CBT-I superior on three out of four sleep measures, both immediately and months later. Participants who received CBT-I improved their sleep efficiency from 81.4% to 90.1% at the six-month follow-up, while the medication group stayed flat at around 82%.
That long-term advantage is the key distinction. Sleep medications typically stop working when you stop taking them. CBT-I teaches skills that continue to improve sleep over time. Many primary care doctors and sleep specialists now consider it the recommended first treatment for chronic insomnia in older adults. It’s available in person, through telehealth, and even through FDA-cleared apps for people who can’t easily access a therapist.
Low-Dose Melatonin: Helpful but Modest
Melatonin is a hormone your body naturally produces to signal that it’s time for sleep. Production declines with age, which is part of why it’s appealing as a supplement. Experts who recommend it for older adults suggest starting with a low dose, as little as 0.3 mg and no more than 2 mg, taken about an hour before bedtime. Most large studies in seniors used 2 mg.
The safety profile is generally favorable. Melatonin has a low potential for abuse and no significant withdrawal effects. Side effects can include residual daytime drowsiness, vivid dreams, mild nausea, and irritability. One concern worth noting: an increased fracture risk has been reported, so seniors already at high risk for falls should weigh this carefully.
The honest limitation is that melatonin’s effect on sleep is modest. It may help you fall asleep slightly faster and stay asleep a bit longer, but it’s not a powerful sedative. For people whose main issue is a shifted sleep schedule (falling asleep too early or too late), it tends to work better than for those with severe, chronic insomnia. Because it’s sold as a supplement in the U.S., doses and purity vary between brands. Look for products with a USP or NSF certification on the label.
Orexin Receptor Antagonists: A Newer Prescription Option
A class of prescription sleep medications called dual orexin receptor antagonists (DORAs) works differently from older sedatives. Instead of broadly suppressing brain activity, these drugs block a specific wakefulness signal. This mechanism appears to produce more natural sleep with fewer of the side effects that make traditional sleep drugs dangerous for seniors.
Clinical trial data on daridorexant, one of the newer drugs in this class, showed that older adults (65 and over) experienced about 20 fewer minutes of nighttime wakefulness and gained roughly 60 additional minutes of self-reported sleep per night compared to placebo at the three-month mark. Critically, the incidence of falls, dizziness, and next-morning drowsiness was comparable to placebo, and in some analyses, orexin blockers were actually associated with fewer falls than placebo. A separate study found that suvorexant, another drug in the same class, significantly decreased fall risk in hospitalized older adults.
No reports of misuse, physical dependence, or withdrawal symptoms have emerged with daridorexant in clinical trials, and dosing does not need to be reduced for older patients. These drugs do require a prescription and can cause occasional sleepiness the next morning or, rarely, sleep paralysis. They are not available over the counter.
Ramelteon: A Prescription Melatonin Alternative
Ramelteon is a prescription drug that works on the same brain receptors as melatonin but with more targeted and consistent action. It’s FDA-approved for insomnia characterized by difficulty falling asleep. It does not appear to increase fall risk. A Japanese hospital study of 360 fall cases found that after adjusting for other risk factors, ramelteon use was not associated with a higher likelihood of falling.
Ramelteon is best suited for people who have trouble initiating sleep rather than staying asleep. It’s not a strong sedative, which is both its limitation and its safety advantage.
What About Trazodone?
Low-dose trazodone, an older antidepressant, is one of the most commonly prescribed off-label sleep aids for seniors. Its sedating effects at low doses make it popular, and it avoids some of the dependency concerns of benzodiazepines. However, it carries real risks for older adults. Trazodone can cause orthostatic hypotension, a sudden drop in blood pressure when standing up, which directly increases fall risk. It also enhances drowsiness and can cause psychomotor impairment, which puts seniors at risk for falls and fractures. Combined with blood pressure medications or other sedating drugs, these effects intensify. It’s not the worst option available, but it’s far from the safest.
Medications Seniors Should Avoid for Sleep
Several categories of sleep-related drugs are broadly considered inappropriate for older adults:
- Benzodiazepines (such as temazepam, lorazepam, diazepam) increase the risk of falls, cognitive impairment, and dependence. They are on the Beers Criteria list.
- First-generation antihistamines (diphenhydramine, doxylamine, promethazine) carry anticholinergic risks including confusion, constipation, and a cumulative association with dementia.
- Z-drugs (zolpidem, eszopiclone, zaleplon) are associated with falls, complex sleep behaviors like sleepwalking, and next-day impairment. The FDA has required lower doses for older adults, but risks remain elevated.
Why Sleep Changes With Age
If you’re over 60 and sleeping differently than you did at 40, that’s largely normal biology, not necessarily a disorder. Deep sleep (slow-wave sleep) decreases across adulthood, while lighter sleep stages increase proportionally. REM sleep declines at a small rate of about 0.6% per decade through age 75, then slightly rebounds. The reassuring finding from meta-analyses is that among healthy adults over 60, sleep architecture remains largely stable. Most age-related sleep changes have already happened by that point.
What this means practically is that waking briefly during the night or sleeping a bit less than you used to isn’t automatically a problem that needs medication. The threshold for treatment is when sleep disruption consistently affects how you feel and function during the day. If that’s the case, starting with CBT-I and, if needed, adding low-dose melatonin or discussing an orexin receptor antagonist with your doctor gives you the best balance of benefit and safety.